Eleven Biotherapeutics Lands $20,000,010 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45d28fee-c244-4e71-8d0b-d34ef78a0e7e
Date
12/8/2014
Company Name
Eleven Biotherapeutics
Mailing Address
215 First Street Cambridge, MA 02142 USA
Company Description
Eleven Biotherapeutics (NASDAQ: EBIO) uses its proprietary technology platform to create first-of-a-kind protein therapeutics to treat ocular diseases in new and effective ways.
Website
http://www.elevenbio.com
Transaction Type
Venture Equity
Transaction Amount
$20,000,010
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor